Emerging Oral Therapies in MS
WebcastFaculty
OVERVIEW
Emerging Oral Therapies in MS is organized by Vindico Medical Education and will be held during Aug 01, 2016 - Jul 31, 2018.
The target audience for this medical event is neurologists other and health care professionals involved in the treatment of patients with MS. This CME Conference has been approved for a maximum of 1.00 AMA PRA Category 1 Credits.
Conference Objectives are :
Upon successful completion of this educational activity, participants should be better able to:
• Evaluate the benefits and limitations of available oral agents for the treatment of relapsing-remitting MS (RRMS). • Review the clinical efficacy and safety of emerging oral therapies for the management of RRMS. • Differentiate available and emerging oral therapies for RRMS management based on mechanism of action, efficacy, and safety.
Additional details will be posted as soon as they are available.
The target audience for this medical event is neurologists other and health care professionals involved in the treatment of patients with MS. This CME Conference has been approved for a maximum of 1.00 AMA PRA Category 1 Credits.
Conference Objectives are :
Upon successful completion of this educational activity, participants should be better able to:
• Evaluate the benefits and limitations of available oral agents for the treatment of relapsing-remitting MS (RRMS). • Review the clinical efficacy and safety of emerging oral therapies for the management of RRMS. • Differentiate available and emerging oral therapies for RRMS management based on mechanism of action, efficacy, and safety.
Additional details will be posted as soon as they are available.
SPECIALITIES
Neurology
Quick Links